MIMETAS

MIMETAS

Biotechnologisch onderzoek

Human Tissue Models for Better Therapies

Over ons

We strive to contribute to groundbreaking therapies with our screenable, physiologically relevant 3D human disease models. By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. For more information, visit: www.mimetas.com.

Branche
Biotechnologisch onderzoek
Bedrijfsgrootte
51 - 200 medewerkers
Hoofdkantoor
Oegstgeest
Type
Particuliere onderneming
Opgericht
2013
Specialismen
organ-on-a-chip, microfluidics, 3D cell culture, cell-based assays, toxicology, tissue models, disease models, microphysiological systems, MPS, organoids, blood-brain barrier, liver, brain models, liver models, kidney models, 3D, disease modeling, phenotypic screening en high-throughput

Locaties

Medewerkers van MIMETAS

Updates

Vergelijkbare pagina’s

Door vacatures bladeren

Financiering

MIMETAS 5 rondes in totaal

Laatste ronde

Toekennen

US$ 3.455.321,00

Bekijk meer informatie over Crunchbase